Genentech’s newly approved multiple sclerosis (MS) injection takes about 10 minutes to administer, dramatically reducing the four to six hours required by its intravenous...
BYLINE: Denise Heady
Newswise — A new study published in NEJM and led by global principal investigator Aditya Bardia, MD, director of Translational Research Integration...
FDA approval of a second strength for HERCESSIÂ paves the way for Accord BioPharma to prepare to commercially launch its first biosimilar; several others are...
Share on PinterestType 2 diabetes is associated with an increased risk of Alzheimer’s and Parkinson’s.According to a new study, certain diabetes medications may significantly...
Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer. | Innovent Biologics has made the...